348340 — Neuromeka Co Balance Sheet
0.000.00%
- KR₩286bn
- KR₩321bn
- KR₩25bn
Annual balance sheet for Neuromeka Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,605 | 15,837 | 28,520 | 40,941 | 20,025 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 750 | 2,709 | 6,885 | 7,673 | 9,766 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,602 | 22,075 | 39,353 | 55,824 | 42,380 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,092 | 1,758 | 4,007 | 14,027 | 25,871 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 12,057 | 24,334 | 43,830 | 95,721 | 95,230 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,070 | 8,479 | 4,022 | 50,801 | 58,241 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 9,871 | 8,769 | 4,103 | 71,665 | 84,360 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 2,186 | 15,565 | 39,727 | 24,056 | 10,869 |
Total Liabilities & Shareholders' Equity | 12,057 | 24,334 | 43,830 | 95,721 | 95,230 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |